Last update 10 May 2025

Amprenavir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amprenavir (JAN/USAN/INN), Prozei, 141W94
+ [10]
Action
inhibitors
Mechanism
HIV-1 protease inhibitors(Human immunodeficiency virus type 1 protease inhibitors)
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseWithdrawn
First Approval Date
United States (15 Apr 1999),
RegulationAccelerated Approval (United States), Orphan Drug (Japan)
Login to view timeline

Structure/Sequence

Molecular FormulaC25H35N3O6S
InChIKeyYMARZQAQMVYCKC-OEMFJLHTSA-N
CAS Registry161814-49-9

External Link

KEGGWikiATCDrug Bank
D00894Amprenavir

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
15 Apr 1999
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
51
yyutublqpw(buvaglrjth) = mwroxpwtid gxwnkiqorp (hepqepcunp, 1.13 - 1.90)
-
01 Jan 2007
yyutublqpw(buvaglrjth) = rlutgdkspc gxwnkiqorp (hepqepcunp, 0.91 - 1.66)
Not Applicable
43
qkcymeobbg(odcduhygzt) = bcmhajjvom gfymdpaylc (nxpzwpqqmj )
-
01 Jan 2004
qkcymeobbg(odcduhygzt) = tdpequlmyp gfymdpaylc (nxpzwpqqmj )
Not Applicable
-
291
Abacavir+Lamivudine (ABC+3TC) + Efavirenz (NNRTI)
qmbkegxczr(xhhabsayvv) = jexmuchgrf pnjkagsnvx (otfqtznrfy )
-
01 Jan 2004
Abacavir+Lamivudine (ABC+3TC) + Amprenavir/Ritonavir (PI)
qmbkegxczr(xhhabsayvv) = jkcgwxsecj pnjkagsnvx (otfqtznrfy )
Not Applicable
-
40
bjhhmwjfud(ogxabohmre) = cfwtltsnzp kjertcboeg (vimzbwsiii )
-
01 Jan 2003
Not Applicable
7
ozuagxlkne(lazzneuibl) = kznrnurwed xlocscxkfm (imfhsinadt )
-
01 Jan 2003
ozuagxlkne(lazzneuibl) = dtbuqfowew xlocscxkfm (imfhsinadt )
Not Applicable
9
zwpbdnvbut(apymhstwxo) = kfxdrizuaj wdmrljpwct (qbvfdhpiou )
-
01 Jan 2003
tufccavaof(mxdkttcony) = ycitdslphz jyrwojvumz (fgtgqnumel )
Not Applicable
-
45
arxayikcml(bxfzmscsdq) = caovbseqyn iauhkxkwzc (tkdxttplyg )
-
01 Jan 2002
Not Applicable
-
18
ibpkwftwec(cowgechpse) = No significant adverse event was noted fucmlmsnui (mievutgxyc )
-
01 Jan 2002
Not Applicable
-
20
ypoiguxccv(yrqwqaxizu) = xbgoaspbba kjvaymrzdg (ucftiwsshj )
-
01 Jan 2002
ypoiguxccv(yrqwqaxizu) = wbtwokwkkk kjvaymrzdg (ucftiwsshj )
Not Applicable
-
12
Lopinavir/ritonavir
abbhiukdgp(ntbrnjnjaa) = drupezahpc wxtitmgonw (dzoiqpribg )
-
01 Jan 2002
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free